Privia Health Group, Inc. (NASDAQ:PRVA) Position Raised by Swiss National Bank

Swiss National Bank increased its position in shares of Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) by 7.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 175,600 shares of the company’s stock after purchasing an additional 11,900 shares during the period. Swiss National Bank’s holdings in Privia Health Group were worth $5,113,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in PRVA. BlackRock Inc. raised its holdings in Privia Health Group by 108.4% during the first quarter. BlackRock Inc. now owns 2,579,166 shares of the company’s stock worth $68,940,000 after purchasing an additional 1,341,730 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Privia Health Group by 34.1% during the first quarter. Bank of New York Mellon Corp now owns 4,138,080 shares of the company’s stock worth $110,611,000 after purchasing an additional 1,052,856 shares in the last quarter. Resources Investment Advisors LLC. bought a new stake in Privia Health Group during the second quarter worth approximately $21,010,000. C WorldWide Group Holding A S bought a new stake in Privia Health Group during the second quarter worth approximately $19,510,000. Finally, Vanguard Group Inc. increased its holdings in shares of Privia Health Group by 16.2% in the first quarter. Vanguard Group Inc. now owns 4,255,881 shares of the company’s stock valued at $113,759,000 after buying an additional 593,178 shares in the last quarter. Institutional investors own 62.81% of the company’s stock.

Privia Health Group Stock Performance

NASDAQ PRVA opened at $22.80 on Friday. Privia Health Group, Inc. has a twelve month low of $17.99 and a twelve month high of $44.64. The stock has a market cap of $2.61 billion, a price-to-earnings ratio of -63.33 and a beta of 0.99. The firm’s 50 day moving average price is $32.02 and its two-hundred day moving average price is $32.07.

Privia Health Group (NASDAQ:PRVAGet Rating) last posted its quarterly earnings data on Thursday, November 10th. The company reported $0.01 earnings per share for the quarter. Privia Health Group had a negative net margin of 3.02% and a negative return on equity of 6.82%. The firm had revenue of $342.90 million for the quarter, compared to analysts’ expectations of $323.66 million. On average, research analysts forecast that Privia Health Group, Inc. will post -0.25 EPS for the current fiscal year.

Insider Activity

In other news, major shareholder Advisors L.L.C. Mbd sold 3,186,888 shares of the business’s stock in a transaction on Monday, November 21st. The shares were sold at an average price of $22.56, for a total transaction of $71,896,193.28. Following the transaction, the insider now directly owns 24,826,071 shares in the company, valued at approximately $560,076,161.76. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, major shareholder Advisors L.L.C. Mbd sold 3,186,888 shares of the business’s stock in a transaction on Monday, November 21st. The shares were sold at an average price of $22.56, for a total transaction of $71,896,193.28. Following the transaction, the insider now directly owns 24,826,071 shares in the company, valued at approximately $560,076,161.76. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Parth Mehrotra sold 138,547 shares of the business’s stock in a transaction on Monday, September 19th. The shares were sold at an average price of $37.84, for a total transaction of $5,242,618.48. Following the transaction, the chief operating officer now owns 97,391 shares in the company, valued at $3,685,275.44. The disclosure for this sale can be found here. Insiders have sold a total of 4,694,328 shares of company stock worth $120,736,870 in the last ninety days. Corporate insiders own 57.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on PRVA shares. BTIG Research upped their price target on Privia Health Group to $45.00 in a report on Monday, August 15th. Truist Financial dropped their price target on Privia Health Group to $41.00 in a report on Thursday, November 17th. Canaccord Genuity Group dropped their price target on Privia Health Group from $50.00 to $43.00 in a report on Friday, November 11th. Cowen upped their price target on Privia Health Group from $35.00 to $44.00 and gave the company an “outperform” rating in a report on Friday, August 12th. Finally, SVB Leerink dropped their price target on Privia Health Group from $46.00 to $39.00 and set an “outperform” rating on the stock in a report on Friday, November 11th. Eleven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $41.08.

About Privia Health Group

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Read More

Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVAGet Rating).

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.